Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Decreases By 16.7%

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 1,620,800 shares, a drop of 16.7% from the January 31st total of 1,946,100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 16,208.0 days.

Ascentage Pharma Group International Stock Performance

Shares of OTCMKTS ASPHF opened at $5.83 on Thursday. The company has a 50-day simple moving average of $6.04 and a 200-day simple moving average of $5.15. Ascentage Pharma Group International has a 12 month low of $5.42 and a 12 month high of $6.45.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.